AstriVax is a privately held spin-off company from the KU Leuven, founded in 2022 based on vaccine technology developed at the Rega Institute. AstriVax is building a first in class Plug & Play vaccine platform with a patented plasmid based technology that launches self-amplifying live attenuated viruses inducing a vigorous and polyfunctional immune response. The versatile technology of AstriVax can be used to develop a wide range of vaccines to prevent and treat infectious diseases. AstriVax aims to address major challenges in vaccinology by developing novel vaccines that are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens. AstriVax will focus on bringing their thermostable yellow fever, rabies and cHBV vaccine to the clinical development stage, thus clinically validating the platform technology for prophylactic and therapeutic use. The company is located in the BioHub in Leuven.
Website
Location: Belgium, Flemish Brabant, Heverlee
Total raised: $32.62M
Investors 4
| Date | Name | Website |
| - | Fund+ | fundplus.b... |
| 31.08.2022 | V-Bio Vent... | v-bio.vent... |
| 01.09.2022 | Korys | korys.be |
| - | KU Leuven ... | lrd.kuleuv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.05.2023 | Grant | $2.68M | - |
| 25.08.2022 | Seed | $29.94M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 12.12.2023 | AstriVax Awarded €3 Million Grant to Advance therapeutic Hep... | - | globenewsw... |
| 30.05.2023 | AstriVax Receives €2.5M Grant | AstriVax, a Leuven, Belgium-based provider of a plug-and-play vaccine platform, received a grant of ... | finsmes.co... |
| 26.09.2022 | Dr Jeanne Bolger to chair Board of Directors of Belgium-base... | Leuven, Belgium, 26 September 2022 – AstriVax has announced that Dr Jeanne Bolger will chair its B... | fundplus.b... |
| 26.09.2022 | AstriVax, an innovative vaccine platform company, establishe... | • Emmanuel Hanon, PhD, will chair the company’s scientific advisory board. • Professor Peter Piot {... | fundplus.b... |
| 25.08.2022 | AstriVax Raises €30M in Seed Funding | Hanne Callewaert, PhD – portrait by Philippe Swiggers AstriVax, a Leuven, Belgium-based KU Leuven s... | finsmes.co... |
| 25.08.2022 | KU Leuven spin-off AstriVax raises € 30 million seed capital... | KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Closing on € 30 million, A... | globenewsw... |
| 25.08.2022 | KU Leuven spin-off AstriVax raises € 30 million to build vac... | KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Leuven, Belgium, 25 Augus... | fundplus.b... |